ArticlePolymers2022
Enhancement of the Properties of Hybridizing Epoxy and Nanoclay for Mechanical, Industrial, and Biomedical Applications.
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 38 citations in OpenAlex.
- Effects of UV irradiation on the structural and optical properties of epoxy/dysprosium nanocomposite sheets for possible UV dosimetry and optoelectronic applications.RSC advances · 2025Article
- Estimation of mass loss under wear test of nanoclay-epoxy nanocomposite using response surface methodology and artificial neural networks.Scientific reports · 2025Article
- Article
- Optimization of the Pentachlorophenol Adsorption by Organo-Clays Based on Response Surface Methodology.Materials (Basel, Switzerland) · 2022Article
- Curing and Molecular Dynamics Simulation of MXene/Phenolic Epoxy Composites with Different Amine Curing Agent Systems.Nanomaterials (Basel, Switzerland) · 2022Article
- Carbon Fiber/PLA Recycled Composite.Polymers · 2022Article
- Mechanical and Moisture Barrier Properties of Epoxy-Nanoclay and Hybrid Epoxy-Nanoclay Glass Fibre Composites: A Review.Polymers · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The strong demand for plastic and polymeric materials continues to grow year after year, making these industries critical to address sustainability. By functioning as a filler in either a synthetic or natural starch matrix, nanoclay enables significant reductions in the impact of nonbiodegradable materials. The effect of treated nanoclay (NC) loading on the mechanical and morphological properties (EP) of epoxy is investigated in this research. The NC-EP nanocomposites were prepared via casting. The investigation begins with adding NC at concentrations of 1, 2, and 3 weight percent, followed by the effect of acid treatment on the same nanocomposites. The evaluation is focused on four mechanical tensile strength parameters: Young's modulus, maximum load, and % elongation. The addition of NC improved the mechanical properties of the four components by 27.2%, 33.38%, 46.98%, and 43.58%, respectively. The acid treatment improved 35.9%, 42.8%, 51.1%, and 83.5%, respectively. These improvements were attributed to NC's ability to alter the structural morphology as assessed by field emission scanning electron microscopy (FESEM), a tool for analysing the microstructure. FESEM images were used to visualise the interaction between the NC and EP nanocomposites. The dynamic mechanical properties of the hybrid nanocomposites were investigated using storage modulus, loss modulus, and tan(delta). The results have shown that the viscoelastic properties improved as the fraction of NC increased. The overall findings suggest that these nanocomposites could be used in various industrial and biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.